2025 Annual Report

✨ AI Summary

This report details EDAN's 2025 performance, highlighting technological innovation and global expansion. Key achievements include significant R&D investment, exceeding 3 billion RMB in cumulative R&D expenditure since IPO, and holding over 1,292 domestic and international patents. The company is transitioning from a follower to a leader in medical technology, with products gaining global recognition and contributing to improved healthcare accessibility.

Summary generated by AI · Always verify with source document